Success Metrics

Clinical Success Rate
90.0%

Based on 27 completed trials

Completion Rate
90%(27/30)
Active Trials
9(16%)
Results Posted
7%(2 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_2
1
2%
Ph not_applicable
51
93%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution52 total trials
Phase 2Efficacy & side effects
1(1.9%)
N/ANon-phased studies
51(98.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.1%

27 of 31 finished

Non-Completion Rate

12.9%

4 ended early

Currently Active

9

trials recruiting

Total Trials

55

all time

Status Distribution
Active(14)
Completed(27)
Terminated(4)
Other(10)

Detailed Status

Completed27
unknown10
Recruiting6
Not yet recruiting4
Terminated3
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
55
Active
9
Success Rate
90.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (1.9%)
N/A51 (98.1%)

Trials by Status

terminated35%
completed2749%
recruiting611%
not_yet_recruiting47%
enrolling_by_invitation12%
unknown1018%
active_not_recruiting35%
withdrawn12%

Recent Activity

Clinical Trials (55)

Showing 20 of 55 trialsScroll for more
NCT05181267Not Applicable

Effects of Intermittent Fasting on Insulin Resistance, Cardiac Metabolism, and Cerebral Perfusion

Completed
NCT07385716Not Applicable

Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome

Completed
NCT06172283Not Applicable

Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Recruiting
NCT04607096Not Applicable

Intermittent Fasting to Improve Insulin Secretion

Recruiting
NCT07513116Not Applicable

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

Not Yet Recruiting
NCT06386887Not Applicable

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Recruiting
NCT07378267Not Applicable

Effect of Intermittent Fasting and Mediterranean Diet on Body Composition and Nutritional Intake

Completed
NCT06766747Not Applicable

Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain After Bariatric Surgery

Completed
NCT06106477Not Applicable

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Recruiting
NCT05869747Not Applicable

Firefighter Collaborative Research Project

Active Not Recruiting
NCT04760847Not Applicable

Intermittent Fasting for Pancreatitis

Not Yet Recruiting
NCT06893913Not Applicable

Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients

Recruiting
NCT06678516Not Applicable

Intermittent Fasting on the Blood Microbiome

Recruiting
NCT06807528Not Applicable

Intermittent Fasting for Inflammation and Depression in Spinal Cord Injury

Not Yet Recruiting
NCT06834256Not Applicable

Intermittent Fasting vs. High-intensity Interval Training on the Lipid Profile of Obese Individuals.

Completed
NCT06299020Not Applicable

Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency

Completed
NCT06804044Not Applicable

Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits

Completed
NCT03590847Not Applicable

Time to Eat Study - Pilot

Completed
NCT06666894Not Applicable

Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients

Completed
NCT06615817Not Applicable

Intermittent Fasting, Mediterranean Diet and NAFLD

Not Yet Recruiting

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
55